LICENSE AGREEMENTLicense Agreement • March 19th, 2021 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This License Agreement (“Agreement”), effective as of March 18, 2021 (the “Effective Date”), is entered into by and among Oramed Pharmaceuticals Inc. and Oramed Ltd. (together, “Oramed”), and Oravax Inc. (“Oravax”).
STOCKHOLDERS AGREEMENTStockholders Agreement • March 19th, 2021 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
THIS STOCKHOLDERS AGREEMENT (this “Agreement”), is made and entered into as of this 18th day of March, 2021, by and among Oravax Medical Inc., a Delaware corporation (the “Company”) and those certain stockholders of the Company listed on Schedule A (together with any subsequent stockholders or holders of options to acquire shares of the capital stock of the Company, or any transferees, who become parties hereto as “Stockholders” pursuant to Subsections 8.1 or 8.2 below, the “Stockholders”).
